行业分析 |
|
|
|
|
国内外单抗药物市场概述 |
李敏1, 吴日伟2 |
1. 江西省科学院科技战略研究所 南昌 330096;
2. 江西省南昌市高新技术产业开发区管理委员会 南昌 330096 |
|
The Market Overview of Monoclonal Antibodies in Both Domestic and Abroad |
LI Min1, WU Ri-wei2 |
1. Institute of Science and Technology Strategy, Jiangxi Academy of Sciences, Nanchang 330096, China;
2. Nanchang National High-Tech Industrial Development, Nanchang 330096, China |
[1] 甄永苏. 抗体药物与肿瘤靶向治疗. 医学研究杂志, 2007, 36(2):1-2. Zhen Y S. Antibody drugs and tumor targeted therapy. Journal of Medical Research, 2007, 36(2):1-2.
[2] 张弢, 陈卫, 浦迪, 等. 抗体药物研究进展与趋势. 中国新药杂志, 2008, 17(9):713-718. Zhang T, Chen W, Pu D, et al. The develpoment and trend of antibody drug. Chinese Journal of New Drug, 2008, 17(9):713-718.
[3] 刘萍, 陈苗苗, 刘学荣,等. 单克隆抗体研究进展. 中国畜牧兽医, 2012, 39(1):67-70. Liu P, Chen M M, Liu X R, et al. Research progress in monoclonal antibodies. China Animal Husbandry & Veterinary Medicine, 2012, 39(1):67-70.
[4] 姚瑞. 单克隆抗体行业研究.成都:西南财经大学, 金融学院, 2014. Yao R. The Monoclonal Antibody Industry Analysis. Chengdu:Southwestern University of Finance and Economics, School of Finance, 2014.
[5] 李壮林, 姚雪静. 单克隆抗体药物研究进展. 药物生物技术, 2014, 21(05):456-461. Li Z L, Yao X J. Research and development of monoclonal antibody drugs. Pharmaceutical Biotechnology, 2014, 21(05):456-461.
[6] Beck A, Wurch T, Reichert T J M. 6th annual report antibody congress 2010. Mabs, 2011, 3(2):111-132.
[7] Weiner L M, Surana R, Wang S. Monoclonal antibodies:versatile platforms for cancer immunotherapy. Nat Rev Immunol, 2010,10(5):317-327.
[8] Chan A C, Carter P J. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol, 2010, 10(5):301-316.
[9] 李心, 龚珉, 徐为人, 等. 抗体药物的国内外市场动态. 现代药物与临床, 2012, 27(3):185-191. Li X, Gong M, Xu W R, et al. Market dynamics of antibody drugs in both domestic and abroad. Drugs & Clinic, 2012, 27(3):185-191.
[10] 马杉姗, 马素永, 赵广荣. 中国抗体药物产业现状与发展前景. 中国生物工程杂志, 2015, 35(12):103-108. Ma S S, Ma S Y, Zhao G R. The status and development prospect of Chinese antibody drug industry. China Biotechnology, 2015, 35(12):103-108.
[11] . Gao K, Wang J Z. The biopharmaceutical industry in China:history and future perspectives. Front Med, 2012, 6(2):101-111.
[12] 王兰,朱磊,徐刚领, 等. 单克隆抗体类生物治疗药物研究进展. 中国药学杂志, 2014, 49(23):2058-2064. Wang L, Zhu L, Xu G L, et al. Progress of research and development of antibody-based therapeutics. Chinese Pharmaceutical Journal, 2014, 49(23):2058-2064. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|